Final Results Reported for EPISOD1 Trial of SOD1-ALS Gene Therapy AMT-162

04 Nov 2026 0 comments

uniQure presented final safety and biomarker results from the discontinued EPISOD1 trial of AMT-162, an investigational gene therapy for SOD1-associated ALS.

Source: NeurologyLive Published 04 Nov 2026 Imported 04 Nov 2026 Relevancy: Not reviewed

Read the article

Comments

No comments yet.

Unrestricted

All comments are reviewed before being published. Most comments are approved unless they are clearly inappropriate or unsafe.

Comments

Leave a comment